Cannabis as Medicine

CBD is Neurotoxic – Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity

Summary: In conclusion, the present study describes the neurotoxicity of CBD above a defined concentration threshold and identifies a potential novel mechanism for this deleterious effect on the neuronal structure and function. Our results have significant implications for clinical utilization and public consumption of CBD and CBD containing products.Further investigations are necessary to firmly establish both the therapeutic […]

CBD is Neurotoxic – Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity Read More »

Cannabis & Female Reproduction – Concerns Continue to Grow

The (endo)cannabinoid signaling in female reproduction: What are the latest advances?Abstract: Cannabis extracts like marijuana have the highest consumption rate worldwide. Yet, their societal acceptance as recreational and therapeutic drugs could represent a serious hazard to female human reproduction, because cannabis ingredients [termed (phyto)cannabinoids] can perturb an endogenous system of lipid signals known as endocannabinoids.

Cannabis & Female Reproduction – Concerns Continue to Grow Read More »

Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration

Abstract (Excerpt): As global interest in the therapeutic potential of cannabis and its’ derivatives for the management of selected diseases increases, it is increasingly imperative that the toxic profile of cannabinoids be thoroughly understood in order to correctly assess the balance between the therapeutic risks and benefits. Modern studies across a number of jurisdictions, including Canada,

Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration Read More »

Study Shows No Benefit With CBD, THC for Peripheral Neuropathic Pain

Jessica Nye, PhD  February 8, 2023Study authors did not identify clear pain-relieving effects from CBD and/or THC among patients with peripheral neuropathic pain and prior treatment failure.Oral cannabidiol (CBD), tetrahydrocannabinol (THC), or their combination did not decrease pain among patients with peripheral neuropathic pain who had a history of treatment failure. These findings, from a

Study Shows No Benefit With CBD, THC for Peripheral Neuropathic Pain Read More »

Labelling of Cannabidiol (CBD) Products: A Public Health Perspective

Conclusions: Accurate and informative labelling of hemp and hemp-derived CBD products is an important public health issue. FDA-regulated product labels are considered an essential tool for protecting consumers and enabling informed decision-making. Untruthful or unsubstantiated health-related claims, and unallowed Drug Claims, in marketing materials and on labels of CBD products may create harm by enticing consumers

Labelling of Cannabidiol (CBD) Products: A Public Health Perspective Read More »

Pre-Conception Cannabis Use Impacts DNA and Influences Offspring Outcomes

Conclusion: This is the first characterization of the effect of cannabis exposure (CE)on the entirety of the rat sperm methylome. We identified CE-associated methylation changes across the sperm methylome, some of which persisted despite a “washout” period. Select methylation changes validated via bisulfite pyrosequencing, and genes associated with methylation changes were involved in early developmental

Pre-Conception Cannabis Use Impacts DNA and Influences Offspring Outcomes Read More »

Cannabis as Pain & Addiction Substitute – The Evidence

The National Academy of Sciences, International Association for the Study of Pain, and other experts have concluded that jurisdiction regulations that allow medical cannabis as an opioid substitute for chronic pain or addiction have at best equivocal evidence regarding safety, efficacy, and comparative effectiveness, and substantial evidence that substituting opioid addiction treatments with cannabis is

Cannabis as Pain & Addiction Substitute – The Evidence Read More »

Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study

Abstract: There is an increase in the medical use of cannabis. However, the safety of medical cannabis, particularly for mental health conditions, has not yet been clearly established. Thus, this study assessed the risk of emergency department (ED) visits and hospitalization for depressive disorders among medical cannabis users. We conducted a retrospective longitudinal cohort study of

Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study Read More »

Cannabis oil failed to improve pain or quality of life in palliative care cancer patients, study shows

Researchers say despite the lack of symptom relief, more trials are needed to focus on the targeted use of medicinal cannabisMelissa Davey 29/11 2022The first high quality study looking at the impact of cannabidiol oil on palliative care patients with advanced cancer found it did not improve their pain, depression, anxiety, or quality of life.Palliative care

Cannabis oil failed to improve pain or quality of life in palliative care cancer patients, study shows Read More »

Scroll to Top